NCT03590600View on ClinicalTrials.gov

A Single Ascending Dose Study of BTZ043

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 7, 2018

Primary Completion Date

August 14, 2018

Study Completion Date

March 5, 2019

Conditions
TuberculosisTuberculosis, PulmonaryBacterial InfectionsLung DiseasesMycobacterium Infections
Interventions
DRUG

BTZ-043

Powder and solvent for oral suspension

DRUG

Placebo

Matching placebo: powder and solvent for oral suspension

Trial Locations (1)

89231

Nuvisan, Neu-Ulm

Sponsors
All Listed Sponsors
collaborator

German Center for Infection Research

OTHER

collaborator

German Federal Ministry of Education and Research

OTHER_GOV

collaborator

Hans Knöll Institute (HKI)

UNKNOWN

lead

Michael Hoelscher

OTHER

NCT03590600 - A Single Ascending Dose Study of BTZ043 | Biotech Hunter | Biotech Hunter